Level Four Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Level Four Advisory Services's REGN Position: Q2 2026 in Review
Level Four Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 56% in Q2 2026, selling an estimated $340K and leaving 396 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #827.
Level Four Advisory Services first reported a position in REGN in Q2 2021 and has held it in 12 quarters since. The position peaked at $2.05M in Q2 2021. 1,335 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Level Four Advisory Services held 396 shares of Regeneron Pharmaceuticals worth $247K as of Q2 2026.
- Level Four Advisory Services sold 499 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $340K.
- Regeneron Pharmaceuticals made up 0.01% of Level Four Advisory Services's portfolio in Q2 2026, its #827 holding.
- Level Four Advisory Services first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
- Level Four Advisory Services's Regeneron Pharmaceuticals position peaked at $2.05M in Q2 2021.
- 1,335 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.